title: Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
authors.forename: Reuben
authors.initials: R
authors.lastname: Granich
authors.forename: Haileyesus
authors.initials: H
authors.lastname: Getahun
authors.forename: Alasdair
authors.initials: A
authors.lastname: Reid
authors.forename: Mario
authors.initials: M
authors.lastname: Raviglione
authors.forename: Kevin M
authors.initials: KM
authors.lastname: De Cock
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D015897:Comorbidity; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D011634:Public Health; D014376:Tuberculosis / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents; D007538:Isoniazid